In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

"This study revealed that exertional dyspnea, exertional palpitations, and decreased nailfold capillary density (≤ seven/mm) serve as useful indicator for considering exercise [right heart ...

March 6 (Reuters) - Merck & Co Inc (MRK.N), opens new tab said on Monday its experimental therapy helped increase exercise capacity in patients with a deadly disease that causes high pressure in blood ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The ...

Please provide your email address to receive an email when new articles are posted on . Sublingual nitroglycerin reduced pulmonary capillary wedge pressure in patients with HF with preserved ejection ...